NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-145-2011-0-US-08 Plasmodial Surface Anion Channel Inhibitors for the Treatment or Prevention of Malaria US National Stage 14/111,256 9320786 Issued PDF
NCI E-117-2011-0-GB-38 Recombinant Immunotoxin Targeting Mesothelin GB EP 12722586.0 Issued
NCI E-117-2011-0-ES-36 Recombinant Immunotoxin Targeting Mesothelin ES EP 12722586.0 Issued
NCI E-117-2011-0-IT-39 Recombinant Immunotoxin Targeting Mesothelin IT EP 12722586.0 Issued
NCI E-117-2011-0-FR-37 Recombinant Immunotoxin Targeting Mesothelin FR EP 12722586.0 Issued
NCI E-117-2011-0-DE-35 Recombinant Immunotoxin Targeting Mesothelin DE EP 12722586.0 Issued
NCI E-117-2011-0-EG-08 Recombinant Immunotoxin Targeting Mesothelin EG National Stage PCT/NA/1697/2013 Abandoned
NCI E-117-2011-0-PE-30 Recombinant Immunotoxin Targeting Mesothelin PE National Stage 2456-02-23 Abandoned
NCI E-750-2013-0-US-01 Methods for Selecting and Treating Lymphoma Types US 61/900,553 Abandoned
NCI E-007-2014-0-US-01 ALK1 ANTIBODIES, CONJUGATES THEREOF, AND THEIR USE US 61/900,806 Abandoned
NIAAA E-258-2012-0-EP-03 Ketone Bodies To Protect Tissues From Damage By Ionizing Radiation EP National Stage 13792209.2 Issued
NIAAA E-258-2012-0-AU-04 Ketone Bodies To Protect Tissues From Damage By Ionizing Radiation AU National Stage 2013337308 Issued
NCI E-117-2011-0-RU-16 Recombinant Immunotoxin Targeting Mesothelin RU National Stage 2013148919 Issued
NCI E-117-2011-0-NZ-14 Recombinant Immunotoxin Targeting Mesothelin NZ National Stage 617386 Abandoned
NIAAA E-258-2012-0-PCT-02 Ketone Bodies To Protect Tissues From Damage By Ionizing Radiation PCT PCT PCT/US2013/068545 Expired
NIAAA E-258-2012-0-CA-05 Ketone Bodies To Protect Tissues From Damage By Ionizing Radiation CA National Stage 2922223 Abandoned
NIAID E-189-2008-2-US-06 LEISHMANIA VACCINE USING SAND FLY SALIVARY IMMUNOGEN US CON 14/069,406 9228002 Issued PDF
NEI E-248-2012-0-PCT-02 Methods of Reducing Adverse Effects in a Cancer Patient Undergoing Treatment with a MEK Inhibitor PCT PCT PCT/US2013/068056 Expired
NCI E-093-2013-1-US-01 COMPOUNDS FOR INHIBITING DRUG-RESISTANT STRAINS OF HIV-1 INTEGRASE US 61/899,061 Abandoned
NEI E-248-2012-0-CA-04 Method of Reducing Adverse Effects in a Cancer Patient Undergoing Treatment with a MEK Inhibitor CA National Stage 2890238 Abandoned
NEI E-248-2012-0-AU-03 Method of Reducing Adverse Effects in a Cancer Patient Undergoing Treatment with a MEK Inhibitor AU National Stage 2013337702 Abandoned
NIDDK E-456-2013-2-PCT-01 Method of Increasing the Amount of Fetal Hemoglobin in a Cell and/or Mammal PCT PCT COMB PCT/US2013/067811 Expired
NIAID E-051-2002-0-US-08 METHOD FOR USING EXTRACELLULAR ADENOSINE INHIBITORS AND ADENOSINE RECEPTOR INHIBITORS TO ENHANCE IMMUNE RESPONSE AND INFLAMMATION US CON 14/067,005 9415105 Expired PDF
NHLBI E-018-2014-0-US-01 Trans-Auricular Left Atrial Appendage Ligation US 61/896,048 Abandoned
NCI E-148-2011-0-US-09 ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III CHIMERIC ANTIGEN RECEPTORS AND USE OF SAME FOR THE TREATMENT OF CANCER US National Stage 14/110,189 9266960 Issued PDF
NCI E-054-2013-2-EP-05 IL-15R ALPHA FORMS, CELLS EXPRESSING IL-15R ALPHA FORMS, AND THERAPEUTIC USES OF IL-15R ALPHA AND IL-15/IL-15R ALPHA COMPLEXES EP National Stage 13849581.7 Issued
NCI E-054-2013-2-AU-03 IL-15R ALPHA FORMS, CELLS EXPRESSING IL-15R ALPHA FORMS, AND THERAPEUTIC USES OF IL-15R ALPHA AND IL-15/IL-15R ALPHA COMPLEXES AU National Stage 2013334610 Issued
NCI E-054-2013-2-JP-07 IL-15R ALPHA FORMS, CELLS EXPRESSING IL-15R ALPHA FORMS, AND THERAPEUTIC USES OF IL-15R ALPHA AND IL-15/IL-15R ALPHA COMPLEXES JP National Stage 2015-539758 Issued
NCI E-054-2013-2-PCT-01 IL-15R ALPHA FORMS, CELLS EXPRESSING IL-15R ALPHA FORMS, AND THERAPEUTIC USES OF IL-15R ALPHA AND IL-15/IL-15R ALPHA COMPLEXES PCT PCT COMB PCT/US2013/066424 Expired
NIAID E-449-2013-0-US-01 Small Molecule Imaging Of Fungi By Positron Emission Tomography Scanning US 61/894,754 Abandoned
NCI E-019-2014-0-US-01 COMPOUNDS THAT BIND TO HIV-1 REV RESPONSE ELEMENTT US 61/894,849 Abandoned
NCI E-520-2013-0-US-01 Identification And Characterization Of HLA-A24 Agonist Epitopes Of MUC1-Oncoprotein US 61/894,482 Abandoned
NIA E-008-2011-0-US-07 Identification Of Stem/Progenitor Cells In Adult Human Pancreas US National Stage 13/981,891 10273458 Issued PDF
NIAID E-263-2005-0-US-07 TARGETING POLY-GAMMA-GLUTAMIC ACID TO TREAT STAPHYLOCOCCUS EPIDERSMIDIS AND RELATED INFECTIONS US DIV 14/058,610 8921071 Issued PDF
NCI E-144-2011-0-US-03 Use of Pyruvate or Succinate to Enhance the Efficacy of a Hypoxia Activated Prodrug for the Treatment of Tumors US National Stage 14/112,906 9402820 Issued PDF
NHLBI E-183-2004-1-US-08 Compositions and Methods for Treating Hyperproliferative Disorders US CON 14/058,000 Abandoned
NCI E-001-2014-0-US-01 ANTIBODIES THAT SPECIFICALLY BIND ATAXIA TELANGIECTASIA-MUTATED AND RAD3-RELATED KINASE PHOSPHORYLATED AT POSITION 1989 AND THEIR USE US 61/893,070 Abandoned
NCI E-002-2014-0-US-01 Human Monoclonal Antibodies Against The Middle East Respiratory Syndrome CoronaVirus (MERS-CoV) And Engineered Bispecific Fusions With Inhibitory Peptides US 61/892,750 Abandoned
NCATS E-010-2013-0-CA-03 Sensor And Device For Real Time Detection Of Plasma Metabolites CA National Stage 2888743 Issued
NCATS E-010-2013-0-JP-05 DEVICE AND METHOD OF USING THE DEVICE FOR DETECTION OF AMINOACIDOPATHY JP National Stage 2015-537847 Issued
NCI E-272-2012-0-PCT-02 Compositions and Methods for Enhancing Cancer Immunotherapy PCT PCT PCT/US2013/065452 Expired
NCATS E-010-2013-0-PCT-02 Sensor And Device For Real Time Detection Of Plasma Metabolites PCT PCT PCT/US2013/065548 Expired
NEI E-099-2010-0-US-06 Methods of Treating Age-Related Macular Degeneration US National Stage 13/977,946 Abandoned
NCI E-033-2008-0-CA-04 THERAPEUTIC APPLICATIONS OF P53 ISOFORMS IN REGENERATIVE MEDICINE, AGING AND CANCER CA National Stage 2705488 Abandoned
NCI E-056-2011-0-KR-12 YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS KR National Stage 10-2013-7027169 Issued
NCI E-056-2011-0-NZ-14 YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS NZ National Stage 616696 Issued
NCI E-130-2011-0-US-05 HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR GLYPICAN-3 AND USE THEREOF US National Stage 14/111,860 9206257 Issued PDF
NHLBI E-759-2013-0-US-01 Vascular Dilators US 61/890,961 Abandoned
NCI E-024-2009-0-GB-13 GENE SIGNATURE FOR PREDICTING PROGNOSIS OF PATIENTS WITH SOLID TUMORS GB EP 13188475.1 Abandoned
NCI E-024-2009-0-DE-11 GENE SIGNATURE FOR PREDICTING PROGNOSIS OF PATIENTS WITH SOLID TUMORS DE EP 13188475.1 Abandoned